结直肠癌生物标志物在诊断和预后中的应用:现状与未来展望  

Application of biomarkers in diagnosis and prognosis of colorectal cancer:a review of recent studies

作　　者：张书婧[1,2] 周庆红 姜伟[3] 刘英华 张静[1,2] 钱智勇[1,2] ZHANG Shu-jing;ZHOU Qing-hong;JIANG Wei;LIU Ying-hua;ZHANG Jing;QIAN Zhi-yong(Health inspection and testing Institute,TianJin Center for Disease Control and Prevention,Tianjin 300011,China;不详)

机构地区：[1]天津市疾病预防控制中心卫生检验检测所,天津300011 [2]国家卫生健康委员会食品安全风险评估与标准研制特色实验室 [3]天津市第一中心医院胃肠外科

出　　处：《环境与健康杂志》2024年第11期1024-1028,共5页Journal of Environment and Health

基　　金：天津市自然基金应用基础研究多元投入青年项目(21JCQNJC01810);天津市医学重点建设学科(TJYXZDXK-066B)。

摘　　要：结直肠癌(colorectal cancer,CRC)是全球范围内常见的恶性肿瘤之一,其早期诊断和预后评估对提高患者生存率和生活质量至关重要。生物标志物作为一种非侵入性且高敏感性的检测手段,近年来在CRC的研究中受到广泛关注。本研究综述了当前CRC生物标志物的研究进展,探讨其在诊断和预后中的应用,并展望其未来的研究方向。Colorectal cancer(CRC)is one of the most common malignancies in the world.The early diagnosis and prognosis assessment are essential to improve the survival rate and quality of patient.In recent years,as a non-invasive and highly sensitive means of detection,biomarkers have received extensive attention in the research of CRC.In this paper,we reviewed the current research progress of CRC biomarkers,discussed their application in diagnosis and prognosis,and looked forward to the future research.

关 键 词：结直肠癌 生物标志物 诊断 预后 

分 类 号：R994.6[医药卫生—毒理学]